Details

Nove metode vrednotenja afinitete fagnih klonov iz bakteriofagnih knjižnic : [enoviti magistrski študijski program farmacija]
ID Žel, Mateja (Author), ID Lunder, Mojca (Mentor) More about this mentor... This link opens in a new window, ID Vodnik, Miha (Comentor)

URLURL - Presentation file, Visit http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/magistrske/2015/Zel_Mateja_mag_nal_2015.pdf This link opens in a new window

Language:Slovenian
Keywords:bakteriofagi, nitasti bakeriofagi M13, encimsko imunski test, afiniteta bakteriofagov, izotermna titracijska kalorimetrija, površinska plazmonska resonanca, biotin
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:FFA - Faculty of Pharmacy
Place of publishing:Ljubljana
Publisher:[M. Žel]
Year:2015
Number of pages:51 f.
PID:20.500.12556/RUL-81324 This link opens in a new window
UDC:578.5(043.3)
COBISS.SI-ID:3811441 This link opens in a new window
Publication date in RUL:11.04.2016
Views:2189
Downloads:430
Metadata:XML DC-XML DC-RDF
:
ŽEL, Mateja, 2015, Nove metode vrednotenja afinitete fagnih klonov iz bakteriofagnih knjižnic : [enoviti magistrski študijski program farmacija] [online]. Master’s thesis. Ljubljana : M. Žel. [Accessed 15 June 2025]. Retrieved from: http://www.ffa.uni-lj.si/fileadmin/datoteke/Knjiznica/magistrske/2015/Zel_Mateja_mag_nal_2015.pdf
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:New methods for evaluation affinity of phage clones from phage display libraries

Similar documents

Similar works from RUL:
  1. Tarčno zdravljenje raka s protitelesi
  2. Študija prisilne razgradnje terapevtskega monoklonskega protitelesa
  3. Preučevanje vpliva ultrafiltracije in diafiltracije na tvorbo proteinskih agregatov
  4. Modeliranje kinetike vezave monoklonskih protiteles na receptor FcγRIIIa
  5. Identifikacija in ločba nezaželenih izooblik pri proizvodnji monoklonskih protiteles
Similar works from other Slovenian collections:
  1. Development and characterization of a novel mAb against bilitranslocase - a new biomarker of renal carcinoma
  2. Zdravljenje raka z modifikatorji biološkega odziva
  3. Advantages offered by the nanobody format when highly-specific reagents are needed for biotechnological applications
  4. Revmatološki neželeni učinki ob zdravljenju raka z imunoterapijo
  5. Pre-immune nanobody collections and their biotechnological applications

Back